Non-pharmacological approaches to the prevention and treatment of Alzheimer’s disease with respect to the rising treatment costs

Current Alzheimer Research

Volumn 13, Issue 11, 2016, Pages 1249-1258

  Klimova, Blanka ^a   Maresova, Petra ^a   Kucaa, Kamil ^a,b  

^a UNIVERSITY OF HRADEC KRALOVE   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Alzheimer s disease; Comparison; Costs; Non pharmacological approaches

Indexed keywords

DONEPEZIL; GALANTAMINE; MEMANTINE; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; RIVASTIGMINE;

ALZHEIMER DISEASE; ART THERAPY; ARTICLE; CLINICAL EVALUATION; CLINICAL RESEARCH; COGNITIVE DEFECT; COGNITIVE THERAPY; DATA BASE; DEMENTIA; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; LONG TERM CARE; MEDITERRANEAN DIET; MILD COGNITIVE IMPAIRMENT; MUSIC THERAPY; PHYSICAL ACTIVITY; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SCIENCEDIRECT; SYMPTOM; SYSTEMATIC REVIEW; WEB OF SCIENCE; COGNITION DISORDERS; COMPLICATION; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; GLOBAL HEALTH; MALE; PROCEDURES;

ALZHEIMER DISEASE; COGNITION DISORDERS; COST-BENEFIT ANALYSIS; FEMALE; GLOBAL HEALTH; HEALTH CARE COSTS; HUMANS; MALE;

EID: 84995752432     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205013666151116142302     Document Type: Article

References (70)

1. Kar N. Cognitive behavioral therapy for the treatment of psttraumatic stress disorder: A review. Neuropsychiatr Dis Treat 7: 167-181 (2011).
2. Xu W, Ferrari C, Wang, HX. Epidemiology of Alzheimer’s Disease. In Mental and Behavioural Disorders and Diseases of the Nervous System, USA: In: Tech p. 376 (2013).
3. Covinsky KE, Newcomer R, Fox P, Wood J, Sands L, Dane K, et al. Patient and caregiver characteristics associated with depression in caregivers of patients with dementia. J Gen Intern Med 18: 1006-1014 (2003).
4. Schoenmakers B, De Lepeleire J, Ylieff M, Fontaine O, Buntinx F. The burden of family care giving in Dementia. Arch Public Health 62: 157-172 (2004)
5. Gerves Ch, Chauvin P, Bellanger MM, Meidani A. Evaluation of full costs of care for patients with Alzheimer’s disease in France: The predominant role of informal care. Health Policy 116(1): 201- 217 (2014).
6. Moore MJ, Zhu CW, Clipp EC. Informal costs of dementia care: estimates from the National Longitudinal Caregiver Study. J Gerontol B Psychol Sci Soc Sci 56: S219-228 (2001).
7. Jones RW, Romeo R, Trigg R, Knapp M, Sato A, King D, et al. Dependence in Alzheimer’s disease and service use costs, quality of life, and caregiver burden: The DADE study. Alzheimer’s Dement 11(3): 280-90 (2015).
8. Maurer K, Volk S, Gerbaldo H. Auguste D and Alzheimer’s disease. Lancet 349: 1546-1549 (1997).
9. Burns A, IIiffe S. Alzheimer’s disease. BMJ 338: b 158 (2009).
10. Shivanand P. Review on Alzheimer’s disease: its cause, symptoms, and treatment at worldwide. Intern J App Biol Pharmaceuti Techno 1(1): 112-120 (2009).
11. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging- Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7(3): 280-292 (2011).
12. Alzheimer’s Association. Alzheimer’s Association Report. 2015 Alzheimer’s disease facts and figures. Alzheimer’s & Dementia 11: 332-384 (2015).
13. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Arch Neurol 60: 1385-1389 (2003).
14. Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, et al. The Mayo Clinic Study of Aging: Design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 30: 58-69 (2008).
15. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, De-Kosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA 288: 1475-1483 (2002).
16. Ferris SH, Farlow M. Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors, Clin Interv Aging 8: 1007-1014 (2003).
17. Maresova P, Klimova B, Kuca K. Alzheimer’s disease: Cost cuts call for novel drugs development and national strategy. Ceska a slovenska Farmacie 64(1-2): 25-30 (2015).
18. Kivipelto M, Solomon A. Alzheimer’s disease - The ways of prevention. J Nutr Health Aging 12: 89S-94S (2007).
19. Marešova P, Mohelska H, Dolejš J, Kuča K. Socio-economic Aspects of Alzheimer’s Disease. Curr Alzheimer Res 12(9): 903-911 (2015).
20. Olazaran J, Reisberg B, Claee L, Cruz T, Pena-casanava J, Del Ser T, et al. Non-pharmacological therapies in Alzheimer’s disease: a systematic review of efficacy. Dement Geniatr Cogn Disord. 30: 161-178 (2010).
21. Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD. Openlabel, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol 58: 427e33 (2001).
22. Koukolik F, Jirak, R. Alzheimerova nemoc a dalši demence. Vyd. 1. Praha: Grada: 20-1 (1998).
23. Nooyens AC, Bueno-de-Mesquita HB, van Boxtel MP, van Gelder BM, Verhagen H, Monique Verschuren WM. Fruit and vegetace intake and cognitive dechne in middle-aged men and women: Doetinchem Cohort Study. Br J Nutr 1-10 (2011).
24. Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imimbo BP, et al. Diet and Alzheimers _s disease risk factors of preventiv: the current evidence. Expert Rev Neurother 11(5): 677-708 (2011).
25. Barnes DE, Yaffe K. The projected eff ect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol 10: 819-28 (2011).
26. Middleton L, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol 66(10): 1210-1215 (2009).
27. Ostergaard SD, Mukherjek S, Sharp SJ, et al. Associations between potentially modifiable risk factors and Alzheimer disease: A Mendelian randomization study. PLoS Med 12(6): e1001841 (2015).
28. Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol 13: 788-794 (2004).
29. Klimova B, Kuca K. Alzheimer’s disease: Potential preventive, non-invasive, intervention strategies in lowering the risk of cognitivedecline – a review study. JAB 13(4): 257-261 (2015).
30. Balbag MA, Pedersen NL, Gatz M. Playing a musical instrument asa protective factor against dementia and cognitive impairment: apopulation-based study. Intern J Alzheimers Dis 1-6 (2014).
31. Tai SY, Wang LC, Yang YH. Effect of music intervention on the cognitive and depression status of senior apartment residents inTaiwan. Neuropsychiatr Dis Treat 11: 1449-1454 (2015).
32. Buchman AS, Boyle PA, Yu L, Shah RC, Wilson RS, Bennett DA, et al. Total daily physical activity and the risk of AD and cognitivedecline in older adults. Neurology 24: 1323-1329 (2012).
33. Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive functionin older adults at risk for Alzheimer disease: A randomized trial. JAMA 300(9): 1027-1037 (2008).
34. Paillard, T. Preventive effects of regular physical exercise against cognitive decline and the risk of dementia with age advancement. Sports Med 4: 1-6 (2015).
35. Voelcker-Rehage C, Niemann C. Structural and functional brain changes related to different types of physical activity across the life span. Neurosci Biobehav Rev 37: 2268-95 (2013).
36. Bialystok E, Craik FL, Freedman M. Bilingualism as a protection against the onset of symptoms of dementia. Neuropsychologia 45: 459-464 (2007).
37. Craik FIM, Bialystock E, Freedman M. Delaying the onset of Alzheimer’s disease. Bilingualism as a form of cognitive reserve. Neurology 75(19): 1726-1729 (2010).
38. Arab, L, and Sabagh, MN. Are certain life style habits associated with lower Alzheimer disease risk? Alzheimers Dis 20(3): 785-794 (2010).
39. Scarmeas N, Luchsinger JA, Schupf N, Brickman AM, Cosentino S, Tang MX, et al. Physical activity, diet, and risk of Alzheimer disease. JAMA 302(6): 627-637 (2009).
40. Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, Kuslansky G, et al. Leisure Activities and the risk of dementia in the elderly. N Engl J Med 348: 2508-2516 (2003).
41. Heyn P, Abreu BC, Ottenbacher KJ. The effects of exercise training on elderly persons with cognitive impairment and dementia: a Meta-analysis. Arch Phys Med Rehabil 85: 1694-1704 (2004).
42. Teri L, Logsdon RG, McCurry SM. Exercise interventions for dementia and cognitive impairment: The Seattle Protocols. J Nutr Health Aging 12(6): 391-394 (2008).
43. Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, Pilotto A, Solfrizzi V. Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. J Alzheimers Dis 22(3): 715-740 (2010).
44. Carballo-Garcia V, Arroyo-Arroyo MR, Portero-Diaz M, Ruiz- Sanchez de Leon JM. Effects of non-pharmacological therapy on normal ageing and on cognitive decline: reflections on treatment objectives. Neurologia 28(3): 160-168 (2013).
45. Hahn EA, Andel R. Nonpharmacological therapies for behavioral and cognitive symptoms of mild cognitive impairment. J Aging Health 23(8): 1223-1245 (2011).
46. Sorman, DE, Sundstrom, A, Ronnlund, M, et al. Leisure activity in old age and risk of dementia: a 15-year prospective study. J Gerontol Series B: Psychol Sci Soc Sci 69(4): 493-501 (2014).
47. Radaka, Z, Marton, O, Nagy, E, et al. The complex role of physical exercise and reactive oxygen species on brain. J Sport Health Sci 2: 87-93 (2013).
48. Audiffren M, Andre N, Albinet C. Effets positifs de l’exercice physique chronique sur les fonctions cognitives des seniors: bilan et perspectives. Rev Neuropsychol 3: 207-225 (2011)
49. Hauer K, Schwenk M, Zieschang T, et al. Physical training improves motor performance in people with dementia: A randomized controlled trial. J Am Geriatr Soc 60(1): 8-15 (2012)
50. Klimova B, Maresova P, Valis M, Hort J, Kuca K. Alzheimer’s disease and language impairments: social intervention and medical treatment. Clinical Interventions in Aging 10: 1401-1407 (2015).